Boeing Slips 3.2% in 3 Months: Is a Better Entry Point Ahead?

Boeing (BA) shares are down 3.2% over three months, but its Defense, Space & Security (BDS) segment grew 13% YoY to $7.48B in Q2 2026 and ended the quarter with an $85B backlog (27% international). The article flags commercial execution risks—aircraft order cancellations of $2.78B in the six months ended June 30, 2026 (mainly 737) and the 777X delayed to a 2027 entry-into-service date with cost overruns. Zacks consensus points to 2026 EPS growth of +91.82% YoY, with liquidity supported by a 1.14 current ratio and shares trading at a forward 12-month P/S of 1.55X vs the industry’s 2.36X.

Analysis

BA is still trading like a balance-sheet-and-execution story, not a simple valuation gap. The market is likely giving too much credit to defense backlog while underweighting how slow commercial normalization keeps inventory, working capital, and confidence depressed; that usually caps multiple expansion even when sales stabilize. In other words, the defense book can slow the bleed, but it does not fully re-rate the equity until commercial delivery cadence becomes visibly cleaner.

Relative winners remain higher-quality defense primes with better cash conversion and less program risk, especially LMT and, to a lesser extent, NOC. BA’s defense mix is helpful, but it is more of a stabilizer than a growth engine; if commercial issues persist, capital will stay trapped in low-return programs and the market will continue to discount forward EPS as less reliable than consensus implies. The second-order effect is that aerospace supply-chain vendors and narrow-body adjacent peers could see more order share migration if customers diversify away from BA exposure.

The key risk window is 1-3 quarters: order cancellations, certification slippage, or trade-related delivery disruptions can quickly reset estimates again. The contrarian miss is that the stock may look cheap on sales multiples because investors are extrapolating the defense backlog and ignoring that a low P/S is often a value trap when free cash flow timing is uncertain. What would falsify the bearish tilt is a clean run of production/inspection improvement plus evidence that cancellations are slowing; absent that, this remains a stock to buy only after execution proof, not before it.

Key Decisions for Investors

• Prefer LMT over BA on a 3-6 month view: long LMT / short BA as a relative-value pair. Thesis: LMT’s growth is higher quality and more self-funding, while BA’s re-rating is hostage to execution; stop the pair if BA shows two consecutive quarters of improving commercial deliveries and lower cancellations.
• Avoid initiating fresh long BA here; wait for a post-earnings or post-regulatory pullback and require evidence of better delivery cadence before sizing. If BA can’t convert backlog into cash flow within the next 1-2 quarters, the discount is likely to stay a discount.
• For downside protection, consider a 3-6 month BA put spread rather than outright shorting shares. The setup is asymmetric because any positive headline can squeeze the name, but further execution disappointment can still reprice the stock lower without needing a macro recession.
• Watch NOC as the cleaner defense exposure if you want sector participation without BA-specific operating risk. A long NOC / short BA pair makes sense over 6-12 months if defense budgets stay firm and commercial aerospace headlines remain messy.
• Trigger-based alert: if BA order cancellations stop accelerating and 777X timing holds for multiple quarters, reassess. Until then, treat any rally as a tactical trade rather than a structural long.